The use of nomograms for prognostication of individual cancer patients has been recommended in order to facilitate precision medicine. However, models for patients with soft tissue sarcomas (STSs) are limited because of the rarity and heterogeneity of such cancers. | Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity Report from the Bone and Soft Tissue Tumor Registry in Japan